Protagonist Therapeutics, Inc. (PTGX)

85.67 +2.91 (+3.52%) USD  |  NASDAQ  |  Feb 23, 14:49
More

Protagonist Therapeutics Ending Cash (Quarterly)

Ending Cash (Quarterly) Chart

View Ending Cash (Quarterly) for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Ending Cash (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Ending Cash (Quarterly) Range, Past 5 Years

View Ending Cash (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Ending Cash (Quarterly) Benchmarks

View Ending Cash (Quarterly) Benchmarks
Start Trial
Johnson & Johnson Upgrade
ADMA Biologics, Inc. Upgrade
Glaukos Corp. --
Krystal Biotech, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade